Prescient Therapeutics targets rare T-cell cancer in new clinical trial, doses first patient

By Proactive Investors / May 28, 2025 / www.youtube.com / Article Link

Prescient Therapeutics Ltd CEO James McDonnell talked with Proactive about the initiation of a Phase 2A clinical trial for the ...

Recent News

Major new entrants to large cap TSXV gold stocks

April 13, 2026 / www.canadianminingreport.com

Gold stocks rebound for third week

April 13, 2026 / www.canadianminingreport.com

Base metals outperform over past month

April 06, 2026 / www.canadianminingreport.com

Gold stocks rise for second week

April 06, 2026 / www.canadianminingreport.com

Mining ETF outflows not severe versus December 2025-January 2026 inflows

March 30, 2026 / www.canadianminingreport.com

See all >